Announcements Trials

Browse Landscape

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Specimen Handling 311 Magnetic Resonance Spectroscopy 266 pembrolizumab 251 Carboplatin 184 Cyclophosphamide 176 Biopsy 172 Cisplatin 157 Gemcitabine 134 Paclitaxel 131 Bevacizumab 124 fludarabine 117 Radiotherapy 108 Nivolumab 108 Oxaliplatin 88 Docetaxel 87 Fluorouracil 85 Capecitabine 83 venetoclax 82 Dexamethasone 77 Pemetrexed 72 Rituximab 71 Leucovorin 69 Drug Therapy 69 atezolizumab 67 durvalumab 66 Radiosurgery 65 Blood Specimen Collection 65 Standard of Care 63 Doxorubicin 63 Radiation 61

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sulfonylurea Compounds × 90 days × Clear all

NCT05663515 2026-06-02

EXCEED

AstraZeneca

24,000 enrolled

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡